·BBC NewsUkraine depends on Starlink - can Europe plug the gap?·Al JazeeraBots, deepfakes and surveillance: Israel’s election goes to war online·BBC NewsIsrael to close West Bank crossings on election day as crackdown escalates·The New York TimesIranians Face Anxious Wait as Threat of Attack Looms·The Jerusalem PostTehran threatens strikes on energy, civilian targets, and nuclear escalation if attacked·Hindustan TimesTrump says France 'burning down' because it opens borders to people 'who hate it'; claims protests not related to education·BBC NewsAlmost 1,000 arrested as clashes follow another day of mass protests across France·NBC NewsDemocrats ask judge to dismiss Trump administration’s challenge to Alaska Senate race·Hindustan TimesOver 4 lakh protest across France, nearly 1,000 arrested as protesters clash with cops; pressure mounts on Macron government·The Times of India‘Maybe tomorrow’: Trump hints at fresh Iran strikes as Tehran denies Hormuz deal offer·The New York TimesObama Issues Searing Attacks on Trump, Ramaswamy in Return to Campaign Trail·Hindustan Times‘Ukraine violated Starlink terms, used it to kill people’: Elon Musk admits imposing curbs after Kyiv's access restored·BBC NewsObama attacks Trump as he campaigns for Democrats ahead of midterm elections·New York PostI was at a peaceful Paris protest. Then the violent far-left mob arrived.·The Times of IndiaLula's comeback bid vs Bolsonaro's son: Brazil votes in high-stakes run-off·Al JazeeraMass rally against Netanyahu ahead of pivotal Israeli election·ABC NewsAmy Acton says Trump, Vance should 'look at the facts' after Ramaswamy attack ad·The HillACLU, Common Cause file motion against DOJ over Alaska election certification block·Hindustan TimesTrump hints at fresh Iran strikes as Tehran denies offering deal to reopen Hormuz·CBS NewsMore than 1,000 arrested in France as protesters and police clash·BBC NewsUkraine depends on Starlink - can Europe plug the gap?·Al JazeeraBots, deepfakes and surveillance: Israel’s election goes to war online·BBC NewsIsrael to close West Bank crossings on election day as crackdown escalates·The New York TimesIranians Face Anxious Wait as Threat of Attack Looms·The Jerusalem PostTehran threatens strikes on energy, civilian targets, and nuclear escalation if attacked·Hindustan TimesTrump says France 'burning down' because it opens borders to people 'who hate it'; claims protests not related to education·BBC NewsAlmost 1,000 arrested as clashes follow another day of mass protests across France·NBC NewsDemocrats ask judge to dismiss Trump administration’s challenge to Alaska Senate race·Hindustan TimesOver 4 lakh protest across France, nearly 1,000 arrested as protesters clash with cops; pressure mounts on Macron government·The Times of India‘Maybe tomorrow’: Trump hints at fresh Iran strikes as Tehran denies Hormuz deal offer·The New York TimesObama Issues Searing Attacks on Trump, Ramaswamy in Return to Campaign Trail·Hindustan Times‘Ukraine violated Starlink terms, used it to kill people’: Elon Musk admits imposing curbs after Kyiv's access restored·BBC NewsObama attacks Trump as he campaigns for Democrats ahead of midterm elections·New York PostI was at a peaceful Paris protest. Then the violent far-left mob arrived.·The Times of IndiaLula's comeback bid vs Bolsonaro's son: Brazil votes in high-stakes run-off·Al JazeeraMass rally against Netanyahu ahead of pivotal Israeli election·ABC NewsAmy Acton says Trump, Vance should 'look at the facts' after Ramaswamy attack ad·The HillACLU, Common Cause file motion against DOJ over Alaska election certification block·Hindustan TimesTrump hints at fresh Iran strikes as Tehran denies offering deal to reopen Hormuz·CBS NewsMore than 1,000 arrested in France as protesters and police clash
Share

Archived story6 articles · 5 publishers

Personalized mRNA vaccine cuts melanoma recurrence by 42% in trial

Published
Updated
Reports
6 from 5 publishers

Moderna and Merck's personalized mRNA vaccine for melanoma reduced the risk of cancer recurrence and death by 42% compared with standard treatment in a late-stage trial. The treatment remains experimental, but the results add scientific support for a vaccine-based approach.

AI summary · Original reporting is linked alongside
Personalized mRNA vaccine cuts melanoma recurrence by 42% in trial
Photo: NBC News

How the outlets frame it

5 outlets, each read from its own headline and opening
  • Stands outBBC News (mildly sensational, one-sided).
  • PlainestNew York Post, TIME and 2 more.
Sensational
Measured
Across: does the report cast the development as bad news or good news. Up: does the report play the story up to grab attention. A thin line joins a logo nudged aside to its exact point.

Tap a logo to see the outlet, the headline it was read from, and where it sits on every measure.

FramingClose

Does the report cast the development as bad news or good news?

Between neutral and leans positive; no outlet stands apart.

NegativeNeutralPositive
SensationalismSplit

Does the report play the story up to grab attention?

Split: NBC News and TIME read as measured; BBC News, New York Post and The New York Times as mildly sensational.

MeasuredSensational
Loaded languageAgree

Do the words judge rather than describe?

All 5 read as neutral wording.

NeutralLoaded
SlantOne outlier

Does the report give room to one side only?

BBC News stands apart as one-sided; the other 4 read as straight.

StraightOne-sided
All 5 outlets and the headlines they were read from

Each outlet is read blind: a classifier sees its headline and opening next to the story's own headline, without the outlet's name, and scores how the report presents the story. A logo sits at the classifier's average reading, so it can fall between two levels. These readings compare coverage of this story only; they are not ratings of the outlets.

Where the outlets diverge

Two headlines from opposite ends

  1. Sensationalism · Measured → Sensational

    MeasuredPersonalized mRNA vaccine for melanoma cut risk of cancer’s return in late-stage trialNBC News Mildly sensationalFirst personalised cancer vaccine cuts risk of disease returning in major trialBBC News

  2. Slant · Straight → One-sided

    StraightFirst-of-its-kind cancer vaccine helps reduce chances of melanoma patients’ tumors returning: studyNew York Post One-sidedFirst personalised cancer vaccine cuts risk of disease returning in major trialBBC News

The story as a whole

Read from all the reports together
Relevance to US readers4 of 5

Affects a specific US group

IndirectDirect
Story lifespan3 of 5

Single event

SettledDeveloping
Time pressure2 of 4

No time pressure

SettledBreaking
Are the claims disputed2 of 4

Not disputed in the text

ConsistentContradictory
Political salience1 of 4

Not political

Not politicalCore conflict
Violence reported1 of 5

No violence reported

No violenceDeaths

Other signals

7 found · 14 not present
  • Article typeNews report
  • TopicHealth and medicine
  • What a reader getsNew facts
  • ToneNeutral and factual
  • Market relevanceRelevant to markets
  • Corporate dimensionA product or service
  • Public healthA treatment or drug
  • Policy areanot present
  • Government levelnot present
  • Where it happensunclear
  • Main political actornot present
  • Civil liberties questionnot present
  • Which marketunclear
  • Market horizonnot present
  • Who is economically affectednot present
  • Conflict dimensionnot present
  • Conflict direction reportednot present
  • Humanitarian impactnot present
  • Public safetynot present
  • Scientific evidencenot present
  • Legal risk in the reportingnot present

Outlets frame this story differently.Share the two headlines

grouped.news is free, independent and has no paywall. If it saves you time, chip in.Buy us a coffee ↗

Coming from Ground News?See the free alternative